Literature DB >> 2406227

The cytoarchitecture of the human thymus detected by monoclonal antibodies.

D J Izon1, R L Boyd.   

Abstract

Seven monoclonal antibodies were produced against human thymic stromal cells. The monoclonal antibodies were put into two groups depending on whether the cells they detected were keratin-positive or -negative. Demonstrated in the keratin-negative group were a granular reticular meshwork, a stellate population predominantly in the medulla, and secretory cells associated with Hassall's corpuscles. In the keratin-positive group we showed two extensive epithelial networks, a trabecular and rare medullary epithelial population, and thymus-specific epithelium restricted to the subcapsule and the medulla. A novel finding was that some of the monoclonal antibodies and also OKM1 identified keratin-negative cells within Hassall's corpuscles, which implies that there are macrophages associated with these structures. The monoclonal antibodies should prove useful for separating and classifying subpopulations of stromal cells and also for monitoring changes in the thymic architecture in different thymic pathologies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2406227     DOI: 10.1016/0198-8859(90)90092-4

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  3 in total

1.  T-cell apoptosis and differential human leucocyte antigen class II expression in human thymus.

Authors:  D C Douek; D M Altmann
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

2.  Development of the chick thymus microenvironment: a study by lectin histochemistry.

Authors:  J G Fernandez; A J Sanchez; C Melcon; C A Chamorro; C Garcia; P Paz
Journal:  J Anat       Date:  1994-02       Impact factor: 2.610

3.  Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts.

Authors:  L Crisa; M T McMaster; J K Ishii; S J Fisher; D R Salomon
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.